bendamustine,nous-209
nouscom,janssen
['nous209', 's209', 'nouscom']
#nouscom announces positive phase 1 data of #nous209, an 'off-the-shelf' #neoantigen #cancer #immunotherapy for the treatment of d#mmr/#msih #solidtumors, at #asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.